药物对比
Fremanezumab vs Zavegepant
Fremanezumab (Ajovy) vs Zavegepant (Zavzpret): CGRP migraine comparison. Monthly prevention injection vs nasal acute treatment. Efficacy, safety, and uses.
此页面暂无可用的对比维度。
临床背景
This comparison is triggered when evaluating CGRP pathway drugs for migraine management, specifically distinguishing between preventive and acute therapies.
结论
Neither drug is inherently better; Fremanezumab excels in prevention and Zavegepant in acute treatment, so they address different aspects of migraine care.
全部药物对比